Insider Trading March 20, 2026

Workday Founder Sells $14.25M in Stock as Company Reports Mixed Signals

David Duffield disposes of over 100,000 Class A shares, converts Class B stock, while analysts trim targets amid solid quarterly results and corporate awards

By Maya Rios WDAY
Workday Founder Sells $14.25M in Stock as Company Reports Mixed Signals
WDAY

David A. Duffield, a 10% shareholder in Workday, Inc. (WDAY), sold 104,514 Class A shares on March 18, 2026, for roughly $14.25 million and converted 107,500 Class B shares into Class A shares. The share sales took place as Workday shares have fallen 42% over six months and the company posted Q4 FY2026 results that met revenue expectations and beat earnings. Several brokerages lowered price targets while maintaining mixed ratings. The board also approved a large restricted stock-unit grant for co-founder Aneel Bhusri, and Workday won a significant multi-year deployment with Fairview Health Services.

Key Points

  • Founder Duffield sold 104,514 Class A shares for approximately $14.25 million and converted 107,500 Class B shares into Class A shares - impacts shareholder composition and liquidity.
  • Workday posted Q4 FY2026 results that met revenue forecasts and beat earnings, with operating margin gains credited to slower hiring - relevant to enterprise software and SaaS investors.
  • Several brokerages lowered price targets (DA Davidson to $125, Freedom Capital Markets to $210, BMO Capital to $182) while preserving mixed ratings; the board granted 437,602 RSUs to Aneel Bhusri and Workday won a multi-year Fairview Health Services deployment affecting HR, finance, and supply chain software markets.

David A. Duffield, who holds roughly a ten percent stake in Workday, Inc. (NASDAQ: WDAY), executed a sale of 104,514 shares of the company’s Class A common stock on March 18, 2026. The transactions generated approximately $14.25 million, with execution prices spanning $131.3491 to $134.8671 per share. The disposal occurred while the share price has retraced about 42% over the prior six months and was trading at $135.98 at the time of reporting.

In a related move, Duffield converted 107,500 shares of Class B common stock into Class A common stock at a conversion price of $0. The conversion increases the pool of Class A shares outstanding while reflecting internal repositioning of his holdings.

Market research referenced by InvestingPro characterizes Workday as significantly undervalued and lists it among the Most Undervalued stocks. The analysis highlights the company’s 76% gross profit margin and notes that Workday holds more cash than debt. Investors are directed to 16 additional InvestingPro Tips for expanded data and context on the company’s financial profile.

Operationally, Workday released fourth-quarter results for fiscal 2026 that met revenue forecasts and exceeded consensus earnings estimates. Management attributed an improvement in operating margin to a slower pace of hiring during the quarter.

Despite the quarterly beat, several brokerages adjusted their price targets downward and signaled caution. DA Davidson cut its price target to $125 from $250 while maintaining a Neutral rating, citing guidance that fell short of forecasts for both revenue and profitability. Freedom Capital Markets reduced its target to $210 from $280, retaining a Buy rating but flagging competition risks related to AI developments. BMO Capital trimmed its target to $182 from $204, maintained an Outperform rating, and emphasized uncertainties around growth as Workday continues to prioritize innovation.

Corporate governance actions also drew attention. Workday’s board approved equity awards for Aneel Bhusri, the company’s co-founder and newly appointed CEO. The award consists of restricted stock units for 437,602 shares of Workday Class A common stock, with vesting scheduled over a four-year period.

On the customer front, Workday disclosed a multiyear modernization engagement with Fairview Health Services. The health system selected Workday to replace existing business systems and adopt an integrated platform for human resources, finance, and supply chain management. The initiative will transition 34,000 Fairview employees onto Workday’s software suite over the term of the contract.

Taken together, the insider sale and share-class conversion, the company’s recent financial performance, the analyst adjustments, and the corporate awards and new customer win present a mixed portrait of near-term momentum and continuing uncertainties as Workday focuses on innovation and market competition.


Summary

David Duffield sold 104,514 Class A shares for about $14.25 million and converted 107,500 Class B shares to Class A. Workday met revenue targets and beat earnings in Q4 FY2026, improved operating margins due to slower hiring, yet saw multiple brokers lower price targets amid guidance concerns. The board granted 437,602 RSUs to co-founder Aneel Bhusri, and the company secured a major contract with Fairview Health Services to migrate 34,000 employees to its platform.

Risks

  • Guidance that fell short of analyst forecasts for revenue and profitability prompted price-target reductions - potential risk to investor sentiment in enterprise software and SaaS markets.
  • Competition risks from AI developments were explicitly cited by at least one broker as a factor influencing valuation and outlook - this represents a competitive uncertainty for Workday in the broader software sector.
  • Uncertainties around growth as the company focuses on innovation were noted by analysts, creating potential variability in future revenue and margin trajectories for enterprise software customers and investors.

More from Insider Trading

Control Empresarial Sells 1.158M PBF Energy Shares in $53.4M Transaction Mar 20, 2026 Maze Therapeutics R&D President Sells $736K in Stock After Option Exercise Mar 20, 2026 SoFi EVP Disposes $165,066 of Stock Under Pre-Arranged Plan; Company Sees Mixed Market Signals Mar 20, 2026 Kymera Director Sells 2,500 Shares, Exercises Options Ahead of Analyst Upgrades Mar 20, 2026 Heartflow CEO Executes $243,125 Share Sale Under 10b5-1 Plan Mar 20, 2026